Advertisement

Journal of Urban Health

, Volume 84, Issue 3, pp 455–458 | Cite as

Offers of Hepatitis C Care Do Not Lead to Treatment

  • Bruce R. SchackmanEmail author
  • Paul A. Teixeira
  • Ann B. Beeder
Article

Abstract

Since 2002, clinicians have been encouraged to offer chronic hepatitis C virus (HCV) treatment to patients with injection drug use histories. We conducted 69 baseline and 35 follow-up interviews between September 2002 and November 2004 with HCV patients who were treatment-naïve and receiving regular medical care at an HIV or methadone clinic in New York City at baseline. Of the 31 patients reinterviewed, 20 (65%) were offered treatment but only 2 (7%) were treated. Reasons for failure to be reinterviewed were loss to follow-up at the original site of care (30), death (6), and refusal to be reinterviewed (2). Whereas offers of HCV treatment may be increasing, there is a need to improve continuity of care, patient–provider communication, and patient education regarding HCV treatment options for treatment rates to improve.

Keywords

Health status Hepatitis C treatment HIV coinfection Methadone maintenance treatment. 

Notes

Acknowledgments

The authors gratefully acknowledge Alvin I. Mushlin, M.D., M.Sc. for his input and guidance; Eugenia Curet, Ph.D., Kim Alexander, M.S.W., Cecilia Schamisso, R.N., Jonathan Jacobs, M.D., Catherine Lopez, Leonard Berkowitz, M.D., Heather Wilantewicz, R.P.A.-C., Rose Tirelli, N.P., John Burgess, M.D., and Paul Falk, M.P.A. for their assistance in study recruitment; the study subjects for their participation; Michael Kattan, Ph.D. and Paul Fearn, M.A. for developing the rating scale and standard gamble assessment software; and Brian Edlin, M.D., Andrew Tallal, M.D., M.P.H., Stephen J. Ferrando, M.D., and Edgar Charles, M.D. for helpful comments on a previous draft. This study was supported in part by the New York City Council Speaker’s Fund for Public Health Research and the National Institutes of Health (K01 DA017179).

References

  1. 1.
    Management of Hepatitis C. NIH Consens. State Sci. Statements. 2002;19(3):1–41, Jun 10–12.Google Scholar
  2. 2.
    Schackman BR, Teixeira PA, et al. Evaluation Of Chronic Hepatitis C Health States By Patients Prior To Treatment And By Providers. Chicago, IL: Annual Meeting of the Society for Medical Decision Making; 2003Google Scholar
  3. 3.
    Gandek B, Ware JE, et al. Cross-validation of item selection and scoring for the SF12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171–1401.PubMedCrossRefGoogle Scholar
  4. 4.
    Radloff L. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRefGoogle Scholar
  5. 5.
    Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705–714.PubMedCrossRefGoogle Scholar

Copyright information

© The New York Academy of Medicine 2007

Authors and Affiliations

  • Bruce R. Schackman
    • 1
    Email author
  • Paul A. Teixeira
    • 1
  • Ann B. Beeder
    • 1
  1. 1.Department of Public HealthWeill Medical College of Cornell UniversityNew YorkUSA

Personalised recommendations